LAS VEGAS and PARIS, April 16 /CNW/ -- Skinvisible Pharmaceuticals, Inc.,
a wholly owned subsidiary of Skinvisible, Inc. (OTC Bulletin Board: SKVI /
Website: www.skinvisible.com) is pleased to announce that its marketing
partner, EMD Chemicals Inc., an affiliate of Merck KGaA, Darmstadt, Germany,
will exhibit the Invisicare delivery technology at the "In-Cosmetics"
exhibition in Paris, France, April 17 - 19th, 2007.
The In-Cosmetics event, held annually in Europe, profiles companies with
raw materials and ingredients in the cosmetics, toiletries and personal care
industry. Along with these suppliers, the event attracts R&D, production and
marketing specialists from pharmaceutical and cosmeceutical companies around
EMD Chemicals Inc. ("EMD / Merck KGaA") has an exclusive worldwide sales,
collaboration and distribution agreement for the personal care market
involving Skinvisible's patented polymer-based topical delivery vehicle,
"The In-Cosmetics event in Paris will provide a great opportunity for
Invisicare to be presented by our marketing partner to this important sector
of the cosmetics, toiletries and personal care industry," said Mr. Terry
Howlett, President and CEO of Skinvisible, Inc. "Our scientific research has
proven the ability of Invisicare to hold active ingredients to the skin for
long periods of time while still allowing the skin to breath, and we believe
that advantage is a value-added for any topical skin care product. We are
very excited to have our partner EMD / Merck KGaA meeting one-on-one with
international decision-makers who potentially can benefit from incorporating
our polymer delivery system into their product."
Skinvisible's business model is focused on licensing its proprietary
formulations with Invisicare to pharmaceutical and cosmeceutical companies as
well as assisting companies in revitalizing or enhancing their existing skin
Skinvisible has patented its technology and trademarked its polymer
delivery system, Invisicare. The technology is a combination of hydrophilic
and hydrophobic polymers that hold active ingredients on the skin for extended
periods of time. They are non-occlusive and allow normal skin respiration and
perspiration while moisturizing and protecting against exposure from a wide
variety of environmental irritants. See: www.invisicare.com
About Skinvisible Pharmaceuticals, Inc.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals, Inc. is
a research-and-development company whose primary business objective is to
license its technology and formulated products to manufacturers of Rx and OTC
skincare products. See www.skinvisible.com
About EMD Chemicals Inc.
EMD Chemicals represents the North American chemical sector of Merck
KGaA, Darmstadt, Germany. As an international organization with 1,100
employees and revenues of more than $US 350 million, EMD Chemicals focuses on
specialty chemicals for pharmaceutical, biotech, cosmetic, agricultural,
automotive, plastics, electronics and other industrial applications.
About Merck KGaA, Darmstadt, Germany
Merck is a global pharmaceutical and chemical company with sales of EUR
6.3 billion in 2006, a history that began in 1668, and a future shaped by
about 35,000 employees (including Merck Serono) in 56 countries. In 1917 the
U.S. subsidiary Merck & Co. was expropriated and has been an independent
company ever since.
This press release contains 'forward looking' statements within the
meaning of Section 21A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, and are subject to the
safe harbors created thereby. Such statements involve certain risks and
uncertainties associated with an emerging company. Actual results could differ
materially from those projected in the forward looking statements as a result
of risk factors discussed in Skinvisible, Inc. reports on file with the U.S.
Securities and Exchange Commission (including, but not limited to, a report on
Form 10K for the year ending December 31, 2006.)
Terry Howlett, President/CEO
For further information:
For further information: Terry Howlett, President/CEO, Skinvisible,
Inc., +1-702-433- 7154, email@example.com Web Site: